EYPT vs GNRC · rev $1.2M vs P/E 82, rev $1.17B
Eyepoint Pharmaceuticals Inc (EYPT) versus Generac Holdings Inc (GNRC) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Generac Holdings Inc (GNRC) is a specialty industrial machinery company listed on US.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported GNRC revenue for 2026-06-30 was $1.17B. Net income was $143.2M. Revenue was up 10.8% from 2026-03-31 to 2026-06-30. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
EYPT currently screens at market cap $1.10B. GNRC currently screens at market cap $15.40B and trailing P/E 82.0.
Not investment advice. Open the EYPT and GNRC stock pages for the full models.
Not investment advice.